- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6242
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel RNAi-Based Therapies for Atherosclerosis ; volume:23 ; number:8 ; day:19 ; month:6 ; year:2021 ; pages:1-6 ; date:8.2021
Current atherosclerosis reports ; 23, Heft 8 (19.6.2021), 1-6, 8.2021
- Creator
-
Ruotsalainen, Anna-Kaisa
Mäkinen, Petri
Ylä-Herttuala, Seppo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11883-021-00938-z
- URN
-
urn:nbn:de:101:1-2021101302032461376776
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ruotsalainen, Anna-Kaisa
- Mäkinen, Petri
- Ylä-Herttuala, Seppo
- SpringerLink (Online service)
Other Objects (12)
Nucleic Acid–Based Therapies for Atherosclerosis
Development of novel parvovirus-based anticancer therapies
RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis
Immunotherapy for Atherosclerosis—Novel Concepts
Analysis of cell-based RNAi screens
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Exploring potential novel therapeutic targets for atherosclerosis and atherosclerosis-related pathologies
Development of RNAi-based antiviral therapeutic strategies
RNAi-based bioinsecticide for Aedes mosquito control
Protein-based vehicles for biomimetic RNAi delivery
The RNAi-competent malaria parasite : a novel strategy to knock down plasmodium genes via non-canonical RNAi
The RNAi-Competent Malaria Parasite: A Novel Strategy to Knock Down Plasmodium Genes via Non-Canonical RNAi
Nucleic Acid–Based Therapies for Atherosclerosis
Development of novel parvovirus-based anticancer therapies
RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis
Immunotherapy for Atherosclerosis—Novel Concepts
Analysis of cell-based RNAi screens
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Exploring potential novel therapeutic targets for atherosclerosis and atherosclerosis-related pathologies
Development of RNAi-based antiviral therapeutic strategies
RNAi-based bioinsecticide for Aedes mosquito control
Protein-based vehicles for biomimetic RNAi delivery
The RNAi-competent malaria parasite : a novel strategy to knock down plasmodium genes via non-canonical RNAi
The RNAi-Competent Malaria Parasite: A Novel Strategy to Knock Down Plasmodium Genes via Non-Canonical RNAi
Nucleic Acid–Based Therapies for Atherosclerosis
Development of novel parvovirus-based anticancer therapies
RNAi Screening-based Identification of USP10 as a Novel Regulator of Paraptosis
Immunotherapy for Atherosclerosis—Novel Concepts
Analysis of cell-based RNAi screens
RNAi to treat SARS‐CoV‐2—variant proofing the next generation of therapies
Exploring potential novel therapeutic targets for atherosclerosis and atherosclerosis-related pathologies
Development of RNAi-based antiviral therapeutic strategies
RNAi-based bioinsecticide for Aedes mosquito control
Protein-based vehicles for biomimetic RNAi delivery
The RNAi-competent malaria parasite : a novel strategy to knock down plasmodium genes via non-canonical RNAi